RE:RE:RE:Random Thought...KC, the US is the prize by a huge margin. The European market is minuscule compared to the US so proximity to Europe should really not be a big consideration, especially since Europe also requires EU GMP product. The US is such a massive market with so much potential for Valens, my hope is Valens does some kind of partnership, similar to Australia/Cannvalate model specific initially to one US region where they see the ideal opportunity for their products and skill set.